KemPharm

+$1.27 (+9.51%) Today
+$0.37 (+2.53%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KemPharm and other stocks, options, and ETFs commission-free!

About KMPH

KemPharm, Inc. Common Stock, also called KemPharm, is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs.

CEO
Travis C. Mickle
Employees
22
Headquarters
Celebration, Florida
Founded
2006

KMPH Key Statistics

Market Cap
416.78M
Price-Earnings Ratio
Dividend Yield
Average Volume
982.67K
High Today
$15.50
Low Today
$13.36
Open Price
$13.38
Volume
2.31M
52 Week High
$18.15
52 Week Low
$5.86

KMPH News

BenzingaJun 10

Why This News Could Help KemPharm Stock Break Out: A Technical Analysis

KemPharm Inc. (NASDAQ:KMPH) shares moved higher Thursday after it was announced the company is being added to the Russell 3000 and Russell 2000 indexes based on

KMPH Earnings

-$1.61
-$1.05
-$0.50
$0.06
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure